AIM ImmunoTech Inc. (AIM)
Largest Insider Buys in Sector
AIM Stock Price History Chart
AIM Stock Performance
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic …
Insider Activity of AIM ImmunoTech Inc.
Over the last 12 months, insiders at AIM ImmunoTech Inc. have bought $206,361 and sold $884 worth of AIM ImmunoTech Inc. stock.
On average, over the past 5 years, insiders at AIM ImmunoTech Inc. have bought $127,966 and sold $884 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Equels Thomas K (CEO & President) — $118,187. APPELROUTH STEWART (director) — $48,173. Rodino Peter W III (COO, Secretary, Gen. Counsel) — $25,000.
The last purchase of 22,727 shares for transaction amount of $4,682 was made by Equels Thomas K (CEO & President) on 2024‑12‑18.
List of Insider Buy and Sell Transactions, AIM ImmunoTech Inc.
| 2024-12-19 | Sale | director | 4,580 0.0071% | $0.19 | $884 | 0.00% | ||
| 2024-12-18 | CEO & President | 22,727 0.035% | $0.21 | $4,682 | -5.15% | |||
| 2024-12-02 | director | 11,112 0.0168% | $0.21 | $2,356 | -3.16% | |||
| 2024-11-20 | CEO & President | 145,110 0.2237% | $0.19 | $27,915 | +5.85% | |||
| 2024-11-20 | CEO & President | 85,000 0.1355% | $0.20 | $16,915 | +5.85% | |||
| 2024-11-20 | CEO & President | 60,110 0.0881% | $0.18 | $11,000 | +5.85% | |||
| 2024-11-20 | director | 81,953 0.1267% | $0.19 | $15,817 | +5.85% | |||
| 2024-09-16 | CEO & President | 5,000 0.0089% | $0.30 | $1,515 | -17.58% | |||
| 2024-09-13 | CEO & President | 20,000 0.0363% | $0.31 | $6,160 | -17.48% | |||
| 2024-05-06 | CEO & President | 61,729 0.117% | $0.41 | $25,000 | -24.00% | |||
| 2024-05-06 | COO, Secretary, Gen. Counsel | 30,865 0.0585% | $0.41 | $12,500 | -24.00% | |||
| 2024-03-21 | director | 38,462 0.0806% | $0.39 | $15,000 | -7.84% | |||
| 2024-03-15 | CEO & President | 75,758 0.1551% | $0.33 | $25,000 | +7.75% | |||
| 2024-03-15 | director | 90,910 0.1861% | $0.33 | $30,000 | +7.75% | |||
| 2024-03-15 | COO, Secretary, Gen. Counsel | 37,879 0.0776% | $0.33 | $12,500 | +7.75% | |||
| 2023-11-27 | CEO & President | 33,861 0.0699% | $0.44 | $15,000 | -6.98% | |||
| 2023-09-29 | CEO & President | 22,676 0.0452% | $0.44 | $10,000 | -6.80% | |||
| 2023-08-25 | CEO & President | 8,222 0.0169% | $0.67 | $5,501 | -34.28% | |||
| 2023-08-24 | CEO & President | 14,993 0.0308% | $0.67 | $10,000 | -35.27% | |||
| 2023-07-17 | CEO & President | 16,950 0.0334% | $0.59 | $10,001 | -27.42% |
Insider Historical Profitability
| Equels Thomas K | CEO & President | 1680695 2.6352% | $0.19 | 44 | 0 | <0.0001% |
| APPELROUTH STEWART | director | 355509 0.5574% | $0.19 | 10 | 0 | <0.0001% |
| Rodino Peter W III | COO, Secretary, Gen. Counsel | 212583 0.3333% | $0.19 | 5 | 0 | <0.0001% |
| MITCHELL WILLIAM M | director | 118549 0.1859% | $0.19 | 2 | 1 | <0.0001% |
| BRYAN NANCY | director | 38462 0.0603% | $0.19 | 1 | 0 |
Institutional Investor Ownership
| The Vanguard Group | $936,680.00 | 3.48 | 1.99M | 0% | +$0 | <0.0001 | |
| BlackRock | $328,915.00 | 1.22 | 698,333 | -1.34% | -$4,461.78 | <0.0001 | |
| Geode Capital Management | $165,689.00 | 0.62 | 351,657 | 0% | +$0 | <0.0001 | |
| Renaissance Technologies | $104,000.00 | 0.39 | 220,808 | +9.31% | +$8,854.75 | <0.0001 | |
| State Street | $81,532.00 | 0.3 | 173,103 | 0% | +$0 | <0.0001 |